Wuhan Hygeianey Biological Technology co., LTD

About us
Current location:
Home page
>
>
Non Small Cell Lung Cancer Individualized Target Detection Solution
News

Non Small Cell Lung Cancer Individualized Target Detection Solution

  • Categories:Service
  • Author:
  • Origin:
  • Time of issue:2020-02-20 15:53
  • Views:0

(Summary description)Currently, the incidence and mortality of lung cancer is in the first place among all malignant tumors in china. The NSCLC patients account for 80-85% of the total number of patients with lung cancer, including squamous cell carcinoma, adenocarcinoma, large cell carcinoma, compared with the small cell carcinoma, their cancer cells grow and divide slowly, and their metastasis is relatively late

Non Small Cell Lung Cancer Individualized Target Detection Solution

(Summary description)Currently, the incidence and mortality of lung cancer is in the first place among all malignant tumors in china. The NSCLC patients account for 80-85% of the total number of patients with lung cancer, including squamous cell carcinoma, adenocarcinoma, large cell carcinoma, compared with the small cell carcinoma, their cancer cells grow and divide slowly, and their metastasis is relatively late

  • Categories:Service
  • Author:
  • Origin:
  • Time of issue:2020-02-20 15:53
  • Views:0
Information

Currently, the incidence and mortality of lung cancer is in the first place among all malignant tumors in china. The NSCLC patients account for 80-85% of the total number of patients with lung cancer, including squamous cell carcinoma, adenocarcinoma, large cell carcinoma, compared with the small cell carcinoma, their cancer cells grow and divide slowly, and their metastasis is relatively late.

Drug Type

Target Gene

Sample Type

Targeted drugs

Gefitinib
Erlotinib

EGFR

Fresh tissue, paraffin-embedded tissue, plasma

K-ras

Fresh tissue, paraffin-embedded tissue, plasma

B-raf

PIK3CA

Cetuximab
Panitumumab

K-ras

N-ras

Crizotinib

ALK

Fresh tissue, paraffin-embedded tissue, plasma

ROS1

RET Fuse

Chemotherapeutic agents

Platinum type

ERCC1

Fresh tissue, paraffin-embedded tissue

BRCA1

TP53

Paclitaxel type
Vinblastine, etc

STMN1

TUBB3

Fluorine type

TYMS

TYMP

DPYD

Etoposide

TOP2A

Gemcitabine

RRM1

Irinotecan

UGT1A1

Whole blood

 

Scan the QR code to read on your phone

Previous: None
Next: None
Previous: None
Next: None

Copyright©Wuhan Hygeianey Biological Technology Co., LTD